- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic and prognostic molecular biomarkers for prostate cancer
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 60, Issue 1, Pages 125-141
Publisher
Wiley
Online
2011-12-24
DOI
10.1111/j.1365-2559.2011.04083.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer
- (2015) Sooryanarayana Varambally et al. NEOPLASIA
- Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
- (2015) Kyung Park et al. NEOPLASIA
- Is There a Role for Fatty Acid Synthase in the Diagnosis of Prostatic Adenocarcinoma?
- (2011) Xiaojun Wu et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The Utility of ERG/P63 Double Immunohistochemical Staining in the Diagnosis of Limited Cancer in Prostate Needle Biopsies
- (2011) Oksana Yaskiv et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas
- (2011) Alcides Chaux et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Diagnostic Utility of Novel Immunohistochemical Marker ERG in the Workup of Prostate Biopsies With “Atypical Glands Suspicious for Cancer”
- (2011) Huiying He et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- ERG Transcription Factor as an Immunohistochemical Marker for Vascular Endothelial Tumors and Prostatic Carcinoma
- (2011) Markku Miettinen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular Predictors of Response to Therapy for Breast Cancer
- (2011) Natalie Galanina et al. CANCER JOURNAL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma
- (2011) Malini Srinivasan et al. Diagnostic Pathology
- Confirmation of the Association of TMPRSS2(exon 0):ERG Expression and a Favorable Prognosis of Primary Prostate Cancer
- (2011) Joost L. Boormans et al. EUROPEAN UROLOGY
- Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
- (2011) Carmen Jerónimo et al. EUROPEAN UROLOGY
- Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancer
- (2011) Martin Braun et al. HISTOPATHOLOGY
- Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression
- (2011) Liyang Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Androgen Receptor–Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options
- (2011) Heidy C.J. Jaspers et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Multi-Institutional Study Evaluating the Performance of Prostate Cancer Risk Calculators
- (2011) Robert K. Nam et al. JOURNAL OF CLINICAL ONCOLOGY
- Protein-network modeling of prostate cancer gene signatures reveals essential pathways in disease recurrence
- (2011) James L Chen et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- MicroRNA-100 Expression is Independently Related to Biochemical Recurrence of Prostate Cancer
- (2011) Katia R.M. Leite et al. JOURNAL OF UROLOGY
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice
- (2011) Geert JLH van Leenders et al. MODERN PATHOLOGY
- Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature
- (2011) Mary K Samplaski et al. MODERN PATHOLOGY
- ERG gene rearrangements are common in prostatic small cell carcinomas
- (2011) Tamara L Lotan et al. MODERN PATHOLOGY
- ERG–TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin
- (2011) Sean R Williamson et al. MODERN PATHOLOGY
- Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomas
- (2011) Antoun Toubaji et al. MODERN PATHOLOGY
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- A Tri-Marker Proliferation Index Predicts Biochemical Recurrence after Surgery for Prostate Cancer
- (2011) Sameer Malhotra et al. PLoS One
- ERG gene rearrangement status in prostate cancer detected by immunohistochemistry
- (2011) Sara Moscovita Falzarano et al. VIRCHOWS ARCHIV
- NKX3.1 as a Marker of Prostatic Origin in Metastatic Tumors
- (2010) Bora Gurel et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Molecular sampling of prostate cancer: a dilemma for predicting disease progression
- (2010) Andrea Sboner et al. BMC Medical Genomics
- Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
- (2010) X. Mao et al. CANCER RESEARCH
- Molecular predictive and prognostic markers in colon cancer
- (2010) Thomas Winder et al. CANCER TREATMENT REVIEWS
- Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma
- (2010) Teresa S Kraus et al. Diagnostic Pathology
- Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue marker
- (2010) Verena Tischler et al. HISTOPATHOLOGY
- ERG rearrangement in small cell prostatic and lung cancer
- (2010) Veit J Scheble et al. HISTOPATHOLOGY
- A study of indefinite for dysplasia in Barrett’s oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (α-methylacyl-CoA-racemase)
- (2010) Sunil A Sonwalkar et al. HISTOPATHOLOGY
- TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate☆
- (2010) Charles C. Guo et al. HUMAN PATHOLOGY
- Development of a Diagnostic Microarray Assay to Assess the Risk of Recurrence of Prostate Cancer Based on PITX2 DNA Methylation
- (2010) Philipp Schatz et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Multicenter Clinical Validation of PITX2 Methylation as a Prostate Specific Antigen Recurrence Predictor in Patients With Post-Radical Prostatectomy Prostate Cancer
- (2010) Lionel L. Bañez et al. JOURNAL OF UROLOGY
- DNA methylation of HOXD3 as a marker of prostate cancer progression
- (2010) Ken J Kron et al. LABORATORY INVESTIGATION
- Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials
- (2010) Naoto Kuroda et al. Medical Molecular Morphology
- ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples
- (2010) Yohei Miyagi et al. MODERN PATHOLOGY
- TMPRSS2-ERG gene fusion in transition zone prostate cancer
- (2010) Tarek A Bismar et al. MODERN PATHOLOGY
- ERG rearrangement is present in a subset of transition zone prostatic tumors
- (2010) Sara M Falzarano et al. MODERN PATHOLOGY
- ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
- (2010) Veit J Scheble et al. MODERN PATHOLOGY
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
- (2010) Samson W Fine et al. MODERN PATHOLOGY
- Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort
- (2010) Raquel Esgueva et al. MODERN PATHOLOGY
- Androgen receptors are differentially expressed in Gleason patterns of prostate cancer and down-regulated in matched lymph node metastases
- (2010) Achim Fleischmann et al. PROSTATE
- TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients
- (2010) Cristina Magi-Galluzzi et al. PROSTATE
- Diagnostic biomarkers of prostate cancer
- (2010) Lars Häggarth et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
- Small Cell Carcinoma of the Prostate
- (2009) Wenle Wang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Aberrant Diffuse Expression of p63 in Adenocarcinoma of the Prostate on Needle Biopsy and Radical Prostatectomy: Report of 21 Cases
- (2009) Adeboye O. Osunkoya et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
- (2009) D M Berney et al. BRITISH JOURNAL OF CANCER
- TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
- (2009) Anuradha Gopalan et al. CANCER RESEARCH
- Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer
- (2009) K. G. Hermans et al. CLINICAL CANCER RESEARCH
- Critical review of prostate cancer predictive tools
- (2009) Shahrokh F Shariat et al. Future Oncology
- MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02
- (2009) Li-Yan Khor et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNAs in Cancer: Small Molecules With a Huge Impact
- (2009) Marilena V. Iorio et al. JOURNAL OF CLINICAL ONCOLOGY
- Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
- (2009) Toshiro Migita et al. JNCI-Journal of the National Cancer Institute
- DNA Methylation of the PITX2 Gene Promoter Region is a Strong Independent Prognostic Marker of Biochemical Recurrence in Patients With Prostate Cancer After Radical Prostatectomy
- (2009) Gunter Weiss et al. JOURNAL OF UROLOGY
- Prostate cancer of transition zone origin lacks TMPRSS2–ERG gene fusion
- (2009) Charles C Guo et al. MODERN PATHOLOGY
- ETS gene fusions in prostate cancer
- (2009) Jeremy P. Clark et al. Nature Reviews Urology
- ERG Rearrangement Metastasis Patterns in Locally Advanced Prostate Cancer
- (2009) Sven Perner et al. UROLOGY
- Immunohistochemical Expression of Prostatic Antigens in Adenocarcinoma and Villous Adenoma of the Urinary Bladder
- (2008) Zhaoli Lane et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Partial Atrophy on Prostate Needle Biopsy Cores: A Morphologic and Immunohistochemical Study
- (2008) Wenle Wang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- False Positive Labeling of Prostate Cancer With High Molecular Weight Cytokeratin: p63 a More Specific Immunomarker for Basal Cells
- (2008) Tehmina Z. Ali et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
- (2008) Liesel M FitzGerald et al. BMC CANCER
- GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
- (2008) G Kristiansen et al. BRITISH JOURNAL OF CANCER
- The clinical management of patients with a small volume of prostatic cancer on biopsy: What are the risks of progression?
- (2008) Patricia Harnden et al. CANCER
- Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men
- (2008) Felix K.-H. Chun et al. CANCER
- Active surveillance for early-stage prostate cancer
- (2008) Marc A. Dall'Era et al. CANCER
- Nine-Gene Molecular Signature Is Not Associated with Prostate Cancer Death in a Watchful Waiting Cohort
- (2008) L. A. Mucci et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Testing a Multigene Signature of Prostate Cancer Death in the Swedish Watchful Waiting Cohort
- (2008) L. A. Mucci et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications
- (2008) J.-M. Mosquera et al. CLINICAL CANCER RESEARCH
- TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
- (2008) O. R. Saramaki et al. CLINICAL CANCER RESEARCH
- α-Methylacyl-CoA racemase - an ‘obscure’ metabolic enzyme takes centre stage
- (2008) Matthew D. Lloyd et al. FEBS Journal
- Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features
- (2008) Zhaoli Lane et al. HUMAN PATHOLOGY
- Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer
- (2008) Tobias Zellweger et al. INTERNATIONAL JOURNAL OF CANCER
- Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer
- (2008) Michelangelo Fiorentino et al. LABORATORY INVESTIGATION
- Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
- (2008) Helena Linardou et al. LANCET ONCOLOGY
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
- GOLPH2 and MYO6: Putative prostate cancer markers localized to the Golgi apparatus
- (2008) Shuanzeng Wei et al. PROSTATE
- Active Surveillance for Favorable Risk Prostate Cancer: What Are the Results, and How Safe Is It?
- (2008) Laurence Klotz SEMINARS IN RADIATION ONCOLOGY
- Do Clinically Insignificant Tumors of the Prostate Exist?
- (2008) K. Stamatiou et al. UROLOGIA INTERNATIONALIS
- A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or “insignificant”
- (2008) I.M. van Oort et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy
- (2008) Hideaki Miyake et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Utility of Bcl-2, P53, Ki-67, and Caveolin-1 Immunostaining in the Prediction of Biochemical Failure After Radical Prostatectomy in a Japanese Population
- (2008) Takahiro Goto et al. UROLOGY
- Combined Prostate-specific Antigen Density and Biopsy Features to Predict “Clinically Insignificant” Prostate Cancer
- (2008) Stacy Loeb et al. UROLOGY
- Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability
- (2008) Sven Gunia et al. WORLD JOURNAL OF UROLOGY
- Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men
- (2007) Claudio Jeldres et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started